IFNA2 and COVID-19: A single subcutaneous injection of Peg-IFNα2 was administered to a 25-year-old woman with known TLR3 deficiency [p.(Pro455Ser)] and COVID-19 who had two episodes of herpes simplex encephalitis in childhood, but had no further serious viral infections.